ViewRay Systems, Inc. (VRAYQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST

ViewRay Systems Company Description

ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally.

The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control.

Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers.

The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

On October 26, 2023, the voluntary petition of ViewRay, Inc. for reorganization under Chapter 11 was converted to Chapter 7.

It had filed for Chapter 11 bankruptcy on July 16, 2023.

ViewRay Systems, Inc.
Country United States
Founded 2004
Industry Medical Devices
Sector Healthcare
Employees 295
CEO Paul Ziegler

Contact Details

Address:
2 Thermo Fisher Way
Oakwood, Ohio 44146
United States
Phone 855 915 4558
Website viewraysystems.com

Stock Details

Ticker Symbol VRAYQ
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US92672L1070
SIC Code 3845

Key Executives

Name Position
Paul Ziegler Jr., J.D. President, Chief Executive Officer and Director
Dr. James F. Dempsey Ph.D. Founder and Chief Scientific Officer
Andrew James Hill Senior Vice President of Operations and Development
Matt Harrison Director of Investor Relations
Sanket Shah J.D. Senior Vice President and General Counsel
Julianne Mast Vice President of Human Resources
Dr. Martin Fuss M.D., Ph.D. Chief Medical Officer
Adam Podbelski Senior Vice President of Commercial Operations
Steven Annen Senior Vice President of Global Marketing